This week, we have a conversation about clinical trial design with Gen Li, the president and founder of Phesi, a global provider of patient-centric data analysis.
Earlier this year, Phesi’s global analysis of all clinical trials conducted in 2023 revealed that more than a quarter (28%) of trials...
Published 04/26/24
RTW is a global multi-strategy investment firm focused on supporting innovative biotech and biopharma companies across the US, Europe, and China.
The company invests in both public and private companies across their entire life cycle, with a focus on those addressing next-generation gene and RNA...
Published 04/19/24